JP2014505074A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014505074A5 JP2014505074A5 JP2013551327A JP2013551327A JP2014505074A5 JP 2014505074 A5 JP2014505074 A5 JP 2014505074A5 JP 2013551327 A JP2013551327 A JP 2013551327A JP 2013551327 A JP2013551327 A JP 2013551327A JP 2014505074 A5 JP2014505074 A5 JP 2014505074A5
- Authority
- JP
- Japan
- Prior art keywords
- propoxy
- hydroxy
- isopropylamino
- methyl
- phenylpropionate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161436992P | 2011-01-27 | 2011-01-27 | |
| US61/436,992 | 2011-01-27 | ||
| PCT/US2012/022696 WO2012103314A1 (en) | 2011-01-27 | 2012-01-26 | Methods of treating tachycardia and/or controlling heart rate while minimizing and/or controlling hypotension |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014505074A JP2014505074A (ja) | 2014-02-27 |
| JP2014505074A5 true JP2014505074A5 (enExample) | 2015-03-19 |
Family
ID=45567141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013551327A Withdrawn JP2014505074A (ja) | 2011-01-27 | 2012-01-26 | 血圧低下を最小化しおよび／または制御しながら頻脈を治療しおよび／または心拍数を制御する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US8686036B2 (enExample) |
| EP (1) | EP2667867B1 (enExample) |
| JP (1) | JP2014505074A (enExample) |
| KR (1) | KR20140034729A (enExample) |
| CN (1) | CN103338763A (enExample) |
| AU (1) | AU2012211318C1 (enExample) |
| BR (1) | BR112013016701A2 (enExample) |
| CA (1) | CA2825311A1 (enExample) |
| MX (1) | MX2013008713A (enExample) |
| WO (1) | WO2012103314A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103347513A (zh) | 2011-01-27 | 2013-10-09 | 巴克斯特国际公司 | (s)-艾司洛尔用于控制与心脏病治疗相关的静脉刺激的应用 |
| RU2613564C1 (ru) * | 2015-12-02 | 2017-03-17 | федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Западный государственный медицинский университет имени И.И. Мечникова" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СЗГМУ им. И.И. Мечникова Минздрава России) | Способ прогнозирования интраоперационной артериальной гипотензии при проведении анестезии |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1985004580A1 (en) | 1984-04-09 | 1985-10-24 | American Hospital Supply Corporation | Pharmaceutical composition and method for treatment or prophylaxis of cardiac disorders |
| JPS63502585A (ja) * | 1985-12-04 | 1988-09-29 | ザ デュポン メルク ファーマシュウティカル カンパニー | アリルオキシプロパノ−ルアミン類及びアリルエタノ−ルアミン類の合成法 |
| AU607437B2 (en) * | 1986-09-02 | 1991-03-07 | Du Pont Pharmaceuticals Company | Resolution of dl-methyl 3-(4-(2-hydroxy-3-isopropylamino) propoxy)phenylpropionate((dl-esmolol)) |
| US4857552A (en) * | 1988-06-08 | 1989-08-15 | E. I. Du Pont De Nemours And Co. | Stable pharmaceutical composition |
| US5998019A (en) | 1993-11-16 | 1999-12-07 | Baxter International Inc. | Multi-layered polymer structure for medical products |
| US5849843A (en) | 1993-11-16 | 1998-12-15 | Baxter International Inc. | Polymeric compositions for medical packaging and devices |
| US5977409A (en) * | 1997-04-15 | 1999-11-02 | University Of Toledo | Method of using α-substituted benzylamine chiral auxiliary synthetic reagents |
| TWI277414B (en) * | 2001-01-12 | 2007-04-01 | Baxter Int | Esmolol formulation |
| US6310094B1 (en) | 2001-01-12 | 2001-10-30 | Baxter International Inc. | Ready-to-use esmolol solution |
| WO2005014042A1 (ja) * | 2003-08-08 | 2005-02-17 | Ono Pharmaceutical Co., Ltd. | 短時間型β遮断薬を有効成分とする心拍数減少剤 |
| US20080293814A1 (en) | 2007-05-22 | 2008-11-27 | Deepak Tiwari | Concentrate esmolol |
| CN101323580A (zh) | 2008-07-25 | 2008-12-17 | 河北科技大学 | 手性芳氧丙醇胺类化合物及其盐的合成方法 |
| CN101881755B (zh) | 2009-05-04 | 2013-05-29 | 南京海辰药业有限公司 | 通过高效液相色谱法检测盐酸艾司洛尔光学异构体的方法 |
| CN101891636A (zh) | 2009-05-21 | 2010-11-24 | 南京海辰药业有限公司 | 制备盐酸艾司洛尔光学异构体的新方法 |
| CN102106846A (zh) | 2009-12-23 | 2011-06-29 | 南京海辰药业有限公司 | 左旋盐酸艾司洛尔药物组合物及其制备方法 |
| CN103347513A (zh) | 2011-01-27 | 2013-10-09 | 巴克斯特国际公司 | (s)-艾司洛尔用于控制与心脏病治疗相关的静脉刺激的应用 |
-
2012
- 2012-01-26 AU AU2012211318A patent/AU2012211318C1/en not_active Ceased
- 2012-01-26 WO PCT/US2012/022696 patent/WO2012103314A1/en not_active Ceased
- 2012-01-26 KR KR1020137018030A patent/KR20140034729A/ko not_active Withdrawn
- 2012-01-26 BR BR112013016701A patent/BR112013016701A2/pt not_active IP Right Cessation
- 2012-01-26 CN CN2012800065096A patent/CN103338763A/zh active Pending
- 2012-01-26 MX MX2013008713A patent/MX2013008713A/es active IP Right Grant
- 2012-01-26 JP JP2013551327A patent/JP2014505074A/ja not_active Withdrawn
- 2012-01-26 EP EP12702941.1A patent/EP2667867B1/en not_active Not-in-force
- 2012-01-26 US US13/359,065 patent/US8686036B2/en active Active
- 2012-01-26 CA CA2825311A patent/CA2825311A1/en not_active Abandoned
-
2013
- 2013-11-08 US US14/075,857 patent/US9084763B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11759506B2 (en) | AADC polynucleotides for the treatment of Parkinson's disease | |
| US12319929B2 (en) | Compositions and methods for the treatment of Parkinson's disease | |
| JP6837486B2 (ja) | 加齢に関連する認知障害及び神経炎症を予防及び／又は治療する方法 | |
| JP2014526441A5 (enExample) | ||
| JP2016516016A5 (enExample) | ||
| TW200831078A (en) | Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats | |
| JP2011507857A5 (enExample) | ||
| CN121243170A (zh) | 用于治疗亨廷顿病及其症状的包含普利多匹定及其类似物的组合物 | |
| WO2021007382A1 (en) | Compositions and methods for the treatment of parkinson's disease | |
| Gupta et al. | Comparative evaluation of propofol versus dexmedetomidine infusion for hypotensive anesthesia during functional endoscopic sinus surgery: a prospective randomized trial | |
| Hadaczek et al. | Pharmacokinetics and bioactivity of glial cell line-derived factor (GDNF) and neurturin (NTN) infused into the rat brain | |
| JP5680412B2 (ja) | レオヌリンの使用およびその組成物 | |
| JP5517925B2 (ja) | パーキンソン病治療薬 | |
| Singh et al. | Intravenous dexmedetomidine vs. lignocaine in attenuating the hemodynamic responses during laryngoscopy and endotracheal intubation: a randomized double blind study | |
| Tendulkar et al. | Prospective Comparison of Pressor and Airway Responses to IV Esmolol and IV Dexmedetomidine during Emergence from General Anaesthesia and Extubation. | |
| JP2012502105A5 (enExample) | ||
| JP2016505617A (ja) | 多汗症の治療 | |
| US20230210942A1 (en) | Methods and compositions for modulating endothelial cell dysfunction | |
| CN104379161A (zh) | 促进血管生长的蛋白质及其用途 | |
| WO2016001682A1 (en) | Treatment of hypertransaminasemia | |
| Farag | Dexmedetomidine in the neurointensive care unit | |
| CN110325214A (zh) | 用于预防和治疗神经元损伤的低剂量药物组合 | |
| Banerjee et al. | Comparative study between fentanyl and dexmedetomidine as adjuvant to ropivacaine in supraclavicular brachial plexus block: A prospective and randomized study | |
| JP2014505074A (ja) | 血圧低下を最小化しおよび／または制御しながら頻脈を治療しおよび／または心拍数を制御する方法 | |
| Chunxian et al. | Clinical characteristics of neurogenic hypertension with facial nerve and trigeminal nerve compression and efficacy of microvascular decompression |